Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone and Ethical Decision Making
NCT04865562Phase 4
Key facts
- Status
- Completed
- Start
- Mar 2015
- Primary completion
- May 2016
- Countries
- 1
- Sponsor
- University of Texas at Austin
- Modality
- Small Molecules
- Drugs
- testosterone
- Conditions
- antisocial personality disorder (ASPD)
01
Overview
Phase 4, randomised, triple-blind trial in antisocial personality disorder (ASPD) comparing Testosterone Arm with Placebo Arm (2 arms). Primary endpoint: Average number of 'heads' coin flips participants claim to have obtained at 90 minutes. Started Mar 2015; status: completed.
02
Design
2 arms- Study design
- RandomizedTriple-blind
Testosterone Arm
7mg testosterone propionate administered intranasally
Placebo Arm
Saline solution with 0.5% chlorobutanol administered intranasally
03
Who it enrols
Healthy males aged 18-25 with BMI 18-27 and no history of psychiatric disorders.
04
Endpoints
Primary
Average number of 'heads' coin flips participants claim to have obtained
Beyond the preview
Go deeper on NCT04865562.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04865562.